These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17434307)

  • 1. Cap disease caused by heterozygous deletion of the beta-tropomyosin gene TPM2.
    Lehtokari VL; Ceuterick-de Groote C; de Jonghe P; Marttila M; Laing NG; Pelin K; Wallgren-Pettersson C
    Neuromuscul Disord; 2007 Jun; 17(6):433-42. PubMed ID: 17434307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New morphologic and genetic findings in cap disease associated with beta-tropomyosin (TPM2) mutations.
    Ohlsson M; Quijano-Roy S; Darin N; Brochier G; Lacène E; Avila-Smirnow D; Fardeau M; Oldfors A; Tajsharghi H
    Neurology; 2008 Dec; 71(23):1896-901. PubMed ID: 19047562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cap disease due to mutation of the beta-tropomyosin gene (TPM2).
    Clarke NF; Domazetovska A; Waddell L; Kornberg A; McLean C; North KN
    Neuromuscul Disord; 2009 May; 19(5):348-51. PubMed ID: 19345583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal actin binding of aberrant β-tropomyosins is a molecular cause of muscle weakness in TPM2-related nemaline and cap myopathy.
    Marttila M; Lemola E; Wallefeld W; Memo M; Donner K; Laing NG; Marston S; Grönholm M; Wallgren-Pettersson C
    Biochem J; 2012 Feb; 442(1):231-9. PubMed ID: 22084935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital myopathy with nemaline rods and cap structures caused by a mutation in the beta-tropomyosin gene (TPM2).
    Tajsharghi H; Ohlsson M; Lindberg C; Oldfors A
    Arch Neurol; 2007 Sep; 64(9):1334-8. PubMed ID: 17846275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cap disease uncapped.
    Goebel HH
    Neuromuscul Disord; 2007 Jun; 17(6):429-32. PubMed ID: 17434306
    [No Abstract]   [Full Text] [Related]  

  • 7. Myopathies associated with β-tropomyosin mutations.
    Tajsharghi H; Ohlsson M; Palm L; Oldfors A
    Neuromuscul Disord; 2012 Nov; 22(11):923-33. PubMed ID: 22749895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distal arthrogryposis and muscle weakness associated with a beta-tropomyosin mutation.
    Tajsharghi H; Kimber E; Holmgren D; Tulinius M; Oldfors A
    Neurology; 2007 Mar; 68(10):772-5. PubMed ID: 17339586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel TPM3 mutation in a family with cap myopathy and review of the literature.
    Schreckenbach T; Schröder JM; Voit T; Abicht A; Neuen-Jacob E; Roos A; Bulst S; Kuhl C; Schulz JB; Weis J; Claeys KG
    Neuromuscul Disord; 2014 Feb; 24(2):117-24. PubMed ID: 24239060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actin mutations are one cause of congenital fibre type disproportion.
    Laing NG; Clarke NF; Dye DE; Liyanage K; Walker KR; Kobayashi Y; Shimakawa S; Hagiwara T; Ouvrier R; Sparrow JC; Nishino I; North KN; Nonaka I
    Ann Neurol; 2004 Nov; 56(5):689-94. PubMed ID: 15468086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reason for the low Ca
    Avrova SV; Karpicheva OE; Rysev NA; Simonyan AO; Sirenko VV; Redwood CS; Borovikov YS
    Biochem Biophys Res Commun; 2018 Jul; 502(2):209-214. PubMed ID: 29792862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy.
    Nowak KJ; Wattanasirichaigoon D; Goebel HH; Wilce M; Pelin K; Donner K; Jacob RL; Hübner C; Oexle K; Anderson JR; Verity CM; North KN; Iannaccone ST; Müller CR; Nürnberg P; Muntoni F; Sewry C; Hughes I; Sutphen R; Lacson AG; Swoboda KJ; Vigneron J; Wallgren-Pettersson C; Beggs AH; Laing NG
    Nat Genet; 1999 Oct; 23(2):208-12. PubMed ID: 10508519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in TPM3 are a common cause of congenital fiber type disproportion.
    Clarke NF; Kolski H; Dye DE; Lim E; Smith RL; Patel R; Fahey MC; Bellance R; Romero NB; Johnson ES; Labarre-Vila A; Monnier N; Laing NG; North KN
    Ann Neurol; 2008 Mar; 63(3):329-37. PubMed ID: 18300303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TPM2 mutation.
    Brandis A; Aronica E; Goebel HH
    Neuromuscul Disord; 2008 Dec; 18(12):1005. PubMed ID: 18789687
    [No Abstract]   [Full Text] [Related]  

  • 15. The pathogenesis of ACTA1-related congenital fiber type disproportion.
    Clarke NF; Ilkovski B; Cooper S; Valova VA; Robinson PJ; Nonaka I; Feng JJ; Marston S; North K
    Ann Neurol; 2007 Jun; 61(6):552-61. PubMed ID: 17387733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital myopathies: diseases of the actin cytoskeleton.
    Clarkson E; Costa CF; Machesky LM
    J Pathol; 2004 Nov; 204(4):407-17. PubMed ID: 15495263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alphaTropomyosin mutation alters dimer preference in nemaline myopathy.
    Corbett MA; Akkari PA; Domazetovska A; Cooper ST; North KN; Laing NG; Gunning PW; Hardeman EC
    Ann Neurol; 2005 Jan; 57(1):42-9. PubMed ID: 15562513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in TPM2 and congenital fibre type disproportion.
    Clarke NF; Waddell LB; Sie LT; van Bon BW; McLean C; Clark D; Kornberg A; Lammens M; North KN
    Neuromuscul Disord; 2012 Nov; 22(11):955-8. PubMed ID: 22832343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a founder mutation in TPM3 in nemaline myopathy patients of Turkish origin.
    Lehtokari VL; Pelin K; Donner K; Voit T; Rudnik-Schöneborn S; Stoetter M; Talim B; Topaloglu H; Laing NG; Wallgren-Pettersson C
    Eur J Hum Genet; 2008 Sep; 16(9):1055-61. PubMed ID: 18382475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital myopathy with cap-like structures and nemaline rods: case report and literature review.
    Piteau SJ; Rossiter JP; Smith RG; MacKenzie JJ
    Pediatr Neurol; 2014 Aug; 51(2):192-7. PubMed ID: 25079567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.